Lien Desteghe

Lien Desteghe

Auto-generated profile, based on publicly available information

Lien Desteghe

Department of Cardiology, Antwerp University Hospital , Antwerp

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2016 in EP Europace
Verified
Journal Article
Open access
PDF file
LDLien Desteghe
Lien Desteghe
ZRZina Raymaekers
Zina Raymaekers
MLMark Lutin
Mark Lutin
JVJohan Vijgen
Johan Vijgen
DDDagmara Dilling-Boer
Dagmara Dilling-Boer
HHHein Heidbuchel
Hein Heidbuchel
To determine the usability, accuracy, and cost-effectiveness of two handheld single-lead electrocardiogram (ECG) devices for atrial fibrillation (AF) screening in a hospital population with an increased risk for AF. Hospitalized patients (n = 445) at cardiological or geriatric wards were screened for AF by two handheld ECG devices (MyDiagnostick and AliveCor). The performance of the automated algorithm of each device was evaluated against a full 12-lead or 6-lead ECG recording. All ECGs and monitor tracings were also independently reviewed in a blinded fashion by two electrophysiologists. Time investments by nurses and physicians were tracked and used to estimate cost-effectiveness of different screening strategies. Handheld recordings were not possible in 7 and 21.4% of cardiology and geriatric patients, respectively, because they were not able to hold the devices properly. Even after the exclusion of patients with an implanted device, sensitivity and specificity of the automated algorithms were suboptimal (Cardiology: 81.8 and 94.2%, respectively, for MyDiagnostick; 54.5 and 97.5%, respectively, for AliveCor; Geriatrics: 89.5 and 95.7%, respectively, for MyDiagnostick; 78.9 and 97.9%, respectively, for AliveCor). A scenario based on automated AliveCor evaluation in patients without AF history and without an implanted device proved to be the most cost-effective method, with a provider cost to identify one new AF patient of €193 and €82 at cardiology and geriatrics, respectively. The cost to detect one preventable stroke per year would be €7535 and €1916, respectively (based on average CHA2DS2-VASc of 3.9 ± 2.0 and 5.0 ± 1.5, respectively). Manual interpretation increases sensitivity, but decreases specificity, doubling the cost per detected patient, but remains cheaper than sole 12-lead ECG screening. Using AliveCor or MyDiagnostick handheld recorders requires a structured screening strategy to be effective and cost-effective in a hospital setting. It must exclude patients with implanted devices and known AF, and requires targeted additional 12-lead ECGs to optimize specificity. Under these circumstances, the expenses per diagnosed new AF patient and preventable stroke are reasonable.

1 November 2016 in International Journal of Cardiology
Verified
Journal Article
Closed access
LDLien Desteghe
Lien Desteghe
LELara Engelhard
Lara Engelhard
ZRZina Raymaekers
Zina Raymaekers
KKKiki Kluts
Kiki Kluts
JVJohan Vijgen
Johan Vijgen
HHHein Heidbuchel
Hein Heidbuchel

2 January 2018 in European Heart Journal
Verified
Journal Article
Closed access
PDF file
LDLien Desteghe
Lien Desteghe
JVJohan Vijgen
Johan Vijgen
PKPieter Koopman
Pieter Koopman
DDDagmara Dilling-Boer
Dagmara Dilling-Boer
JSJoris Schurmans
Joris Schurmans
HHHein Heidbuchel
Hein Heidbuchel
To evaluate the effect of telemonitoring on adherence to non-vitamin K antagonist oral anticoagulants (NOACs) in atrial fibrillation (AF) patients. A randomized, single-blind, crossover, controlled trial in 48 AF patients on once or twice daily (OD or BID) NOAC. The Medication Event Monitoring System tracked NOAC intake during three phases of 3 months each: daily telemonitoring, telemonitoring with immediate telephone feedback in case of intake errors, and an observation phase without daily transmissions. Unprotected days were defined as ≥ 3 or ≥ 1 consecutively missed doses for a BID or OD NOAC, respectively, or excess dose intake. Cost-effectiveness was calculated based on anticipated stroke reduction derived from patients’ risk profile and measured intake. Persistence over the entire study was 98%. Telemonitoring-only already led to very high taking and regimen adherence (97.4% respectively 93.8%). Nevertheless, direct feedback further improved both to 99.0% and 96.8%, respectively (P < 0.001 respectively P = 0.002). Observation without daily monitoring resulted in a significant waning of taking adherence (94.3%; P = 0.049). Taking adherence was significantly higher for OD compared to BID NOAC, although unprotected days were similar. Feedback intervention had an incremental cost of €344 289 to prevent one stroke, but this could be as low as €15 488 in high-risk patients with low adherence and optimized technology. Telemonitoring resulted in high NOAC adherence due to the notion of being watched, as evidenced by the rapid decline during the observation period. Feedback further optimized adherence. Telemonitoring with or without feedback may be a cost-effective approach in high-risk patients deemed poorly adherent.

25 August 2023 in EP Europace
Verified
Journal Article
Open access
PDF file
ESEmma Svennberg
Emma Svennberg
Enrico Gianluca CaianiEnrico Gianluca Caiani
Enrico Gianluca Caiani
NBNico Bruining
Nico Bruining
LDLien Desteghe
Lien Desteghe
JHJanet K Han
Janet K Han
DDDavid Duncker
David Duncker
Aims: Over the past 25 years there has been a substantial development in the field of digital electrophysiology (EP) and in parallel a substantial increase in publications on digital cardiology. In this celebratory paper, we provide an overview of the digital field by highlighting publications from the field focusing on the EP Europace journal. Results: In this journey across the past quarter of a century we follow the development of digital tools commonly used in the clinic spanning from the initiation of digital clinics through the early days of telemonitoring, to wearables, mobile applications, and the use of fully virtual clinics. We then provide a chronicle of the field of artificial intelligence, a regulatory perspective, and at the end of our journey provide a future outlook for digital EP. Conclusion: Over the past 25 years Europace has published a substantial number of papers on digital EP, with a marked expansion in digital publications in recent years.

19 July 2017 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
LDLien Desteghe
Lien Desteghe
KKKiki Kluts
Kiki Kluts
JVJohan Vijgen
Johan Vijgen
PKPieter Koopman
Pieter Koopman
DDDagmara Dilling-Boer
Dagmara Dilling-Boer
HHHein Heidbuchel
Hein Heidbuchel
Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.

12 April 2018 in Clinical Research in Cardiology
Verified
Journal Article
Closed access
LDLien Desteghe
Lien Desteghe
JHJeroen M.H Hendriks
Jeroen M.H Hendriks
RMR. Doug McEvoy
R. Doug McEvoy
CCChing Li Chai-Coetzer
Ching Li Chai-Coetzer
PDPaul Dendale
Paul Dendale
Dominik LinzDominik Linz
Dominik Linz